Back to Search Start Over

Transcatheter Valve-in-Valve Implantation With a Novel Balloon-Expandable Device in Patients With Bioprosthetic Heart Valve Failure: A Case Series.

Authors :
Ielasi A
Buono A
Medda M
Casilli F
Bande M
Pellicano M
Glauber M
Donatelli F
Tespili M
Source :
Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2021 Jul; Vol. 28S, pp. 98-101. Date of Electronic Publication: 2020 Nov 18.
Publication Year :
2021

Abstract

Trans-catheter valve-in-valve (ViV) is a treatment option for patients affected by bioprosthetic heart valve (BHV) failure. Both aortic and mitral ViV procedures present several challenges compared to native valve replacement. To date, no data concerning the balloon-expandable MyVal (Meril, Vapi, India) trans-catheter heart valve (THV) use in ViV procedure have been provided. In this case series, we described for the first time its use in five different BHV failures.<br />Competing Interests: Declaration of competing interest Authors have no conflicts of interest to declare.<br /> (Copyright © 2020 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1878-0938
Volume :
28S
Database :
MEDLINE
Journal :
Cardiovascular revascularization medicine : including molecular interventions
Publication Type :
Academic Journal
Accession number :
33250405
Full Text :
https://doi.org/10.1016/j.carrev.2020.11.018